Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's disease

Disentangling the Amyloid Pathways: A Mechanistic Approach to Etiology

(2020) Maja Malmberg et al.   Frontiers in Neuroscience

Amyloid-β Immunotherapy for Alzheimer's Disease - Is It Now A Long Shot…?

(2019) Francesco Panza et al.   ANNALS OF NEUROLOGY

Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease

(2019) Eduardo De Pablo-Fernández et al.   JAMA Neurology

Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies

(2019) Aron S. Buchman et al.   NEUROLOGY

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases

(2019) Alberto J. Espay et al.   NEUROLOGY

Clinical Parkinson disease subtyping does not predict pathology

(2019) Alberto J. Espay et al.   Nature Reviews Neurology

The viral protein corona directs viral pathogenesis and amyloid aggregation

(2019) Kariem Ezzat et al.   Nature Communications

Non-Alzheimer’s contributions to dementia and cognitive resilience in The 90+ Study

(2018) John L. Robinson et al.   ACTA NEUROPATHOLOGICA

Abnormal resting-state functional connectivity in posterior cingulate cortex of Parkinson's disease with mild cognitive impairment and dementia

(2018) Zhou-Wei Zhan et al.   CNS Neuroscience & Therapeutics

Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort

(2018) Tanya Simuni et al.   MOVEMENT DISORDERS

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

(2017) David J Irwin et al.   LANCET NEUROLOGY

Precuneus degeneration and isolated apathy in patients with Parkinson’s disease

(2017) Jung Hwan Shin et al.   NEUROSCIENCE LETTERS

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

(2017) Chelsea Caspell-Garcia et al.   PLoS One

How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?

(2016) Tanya Simuni et al.   PARKINSONISM & RELATED DISORDERS

Validity of modulation and optimal settings for advanced voxel-based morphometry

(2013) Joaquim Radua et al.   NEUROIMAGE

β-amyloid in lewy body disease is related to Alzheimer's disease-like atrophy

(2012) Hitoshi Shimada et al.   MOVEMENT DISORDERS

FreeSurfer

(2012) Bruce Fischl   NEUROIMAGE

The Parkinson Progression Marker Initiative (PPMI)

(2011) Kenneth Marek et al.   PROGRESS IN NEUROBIOLOGY

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

Brain N-acetylaspartate is Reduced in Parkinson Disease With Dementia

(2009) Henry Randall Griffith et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS